MX385466B - Validacion de aclaramiento viral continuo. - Google Patents

Validacion de aclaramiento viral continuo.

Info

Publication number
MX385466B
MX385466B MX2019004540A MX2019004540A MX385466B MX 385466 B MX385466 B MX 385466B MX 2019004540 A MX2019004540 A MX 2019004540A MX 2019004540 A MX2019004540 A MX 2019004540A MX 385466 B MX385466 B MX 385466B
Authority
MX
Mexico
Prior art keywords
viral clearance
probe
validation
continuous viral
continuous
Prior art date
Application number
MX2019004540A
Other languages
English (en)
Spanish (es)
Other versions
MX2019004540A (es
Inventor
Benjamin Maiser
Laura David
Martin Lobedann
Peter Schwan
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX2019004540A publication Critical patent/MX2019004540A/es
Publication of MX385466B publication Critical patent/MX385466B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22—Testing for sterility conditions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MX2019004540A 2016-10-21 2017-10-19 Validacion de aclaramiento viral continuo. MX385466B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16194959.9A EP3141611A3 (en) 2016-10-21 2016-10-21 Validation of continuous viral clearance
PCT/US2017/057298 WO2018075716A1 (en) 2016-10-21 2017-10-19 Validation of continuous viral clearance

Publications (2)

Publication Number Publication Date
MX2019004540A MX2019004540A (es) 2019-06-12
MX385466B true MX385466B (es) 2025-03-18

Family

ID=57209212

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019004540A MX385466B (es) 2016-10-21 2017-10-19 Validacion de aclaramiento viral continuo.

Country Status (16)

Country Link
US (1) US10894991B2 (enExample)
EP (2) EP3141611A3 (enExample)
JP (1) JP2019537435A (enExample)
KR (1) KR20190066017A (enExample)
CN (1) CN110100008A (enExample)
AR (1) AR109846A1 (enExample)
AU (1) AU2017345412A1 (enExample)
BR (1) BR112019007835A2 (enExample)
CA (1) CA3041253A1 (enExample)
IL (1) IL266095A (enExample)
MX (1) MX385466B (enExample)
RU (1) RU2755634C2 (enExample)
SG (1) SG10202104023QA (enExample)
TW (1) TW201827830A (enExample)
UY (1) UY37447A (enExample)
WO (1) WO2018075716A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190022654A1 (en) * 2017-07-10 2019-01-24 Baxalta Incorporated Method for incubating liquids
EP4112735A4 (en) * 2020-02-28 2023-09-06 Asahi Kasei Medical Co., Ltd. METHOD FOR EVALUATING VIRAL CLEARANCE PERFORMANCE
WO2022060535A1 (en) * 2020-09-21 2022-03-24 Bayer Healthcare Llc Pathogen clearance system and method
US12203914B2 (en) * 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
WO2022203044A1 (ja) * 2021-03-26 2022-09-29 旭化成メディカル株式会社 ウイルスクリアランス試験の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184833A1 (en) * 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
AU2014100888A4 (en) * 2014-08-07 2014-09-11 Novartis Ag Virus clearance and protein purification methods

Also Published As

Publication number Publication date
US20190316213A1 (en) 2019-10-17
IL266095A (en) 2019-06-30
EP3529367A1 (en) 2019-08-28
SG10202104023QA (en) 2021-06-29
EP3141611A2 (en) 2017-03-15
TW201827830A (zh) 2018-08-01
WO2018075716A1 (en) 2018-04-26
BR112019007835A2 (pt) 2019-10-01
RU2019115375A3 (enExample) 2021-03-19
UY37447A (es) 2018-05-31
US10894991B2 (en) 2021-01-19
EP3141611A3 (en) 2017-05-10
CA3041253A1 (en) 2018-04-26
AR109846A1 (es) 2019-01-30
JP2019537435A (ja) 2019-12-26
CN110100008A (zh) 2019-08-06
AU2017345412A1 (en) 2019-04-18
RU2755634C2 (ru) 2021-09-17
MX2019004540A (es) 2019-06-12
KR20190066017A (ko) 2019-06-12
RU2019115375A (ru) 2020-11-23

Similar Documents

Publication Publication Date Title
MX2019004540A (es) Validacion de aclaramiento viral continuo.
IL256644B (en) System and method for management, execution, and analysis of laboratory experiments
EP4250151A4 (en) ATTACK ANALYSIS DEVICE, ATTACK ANALYSIS METHOD, AND PROGRAM
EP3327198A4 (en) RISS ANALYSIS DEVICE, RIP ANALYSIS METHOD AND RIP ANALYSIS PROGRAM
EA201790214A1 (ru) Определение одного или нескольких параметров проекта заканчивания скважины на основании данных бурения, соответствующих переменным удельной механической энергии
EA201990986A1 (ru) Способы и системы анализа хроматографических данных
CL2014002551A1 (es) Metodo para identificar segmento de audio, que comprende las etapas de crear un espectrograma del segmento candidato de audio, crear un mapa candidato de bits huella digital y acustica del espectrograma, comparar el mapa candidato con al menos un mapa conocido de un mensaje de red conocido, si el mapa candidato coincide con un mapa conocido, declarar el calce, y si el candidato no coincide, utilizar un algoritmo de deteccion para analizar el segmento de audio candidato; metodos asociados.
EP3344977C0 (en) METHOD AND SYSTEM FOR ANALYZING SAMPLES USING LASER-INDUCED BREAKDOWN SPECTROSCOPY
MX2017001472A (es) Metodo y sistema para obtener informacion geoquimica de pirolisis mediante espectroscopia de descomposicion inducida por laser.
EP3318978A4 (en) SYSTEM AND METHOD FOR THE SEMANTIC ANALYSIS OF LANGUAGE
MX2017006097A (es) Libs para caracterizacion de fluido de materiales porosos.
EP3889797A4 (en) DATABASE INDEX AND DATABASE QUERY PROCESSING METHOD, APPARATUS AND DEVICE
EP3796249A4 (en) SAMPLING MANAGEMENT DEVICE, SAMPLING MANAGEMENT SYSTEM, SAMPLING MANAGEMENT METHOD, AND PROGRAM
Guo et al. A systematic method for analyzing robust stability of interval neural networks with time-delays based on stability criteria
EP2991264A4 (en) SYSTEM, METHOD AND PROGRAM FOR ADAPTING ENCRYPTED TEXTS
EP3297703A4 (en) PHOTOTHERAPY SYSTEM AND METHOD FOR PREVENTING OR TREATING CARBON MONOXIDE POISONING
EP3916655A4 (en) OPERATION ANALYSIS DEVICE, OPERATION ANALYSIS METHOD, OPERATION ANALYSIS PROGRAM AND OPERATION ANALYSIS SYSTEM
EP2991265A4 (en) SYSTEM, METHOD AND PROGRAM FOR ADAPTING ENCRYPTED TEXTS
JP2019537435A5 (enExample)
EP3731108A4 (en) RESEARCH SYSTEM, RESEARCH PROCESS AND PROGRAM
IL254672B (en) Comment analysis system, comment analysis method, and program for comment analysis
EP3540043A4 (en) ANALYSIS DEVICE, ANALYSIS METHOD, AND PROGRAM
EP3839780A4 (en) DETECTOR, DETECTION METHOD AND DETECTION PROGRAM
EP4043542C0 (en) PROGRAM, DEVICE AND ANALYSIS METHOD
EP4040162A4 (en) DEVICE, METHOD AND ANALYSIS PROGRAM